跳至主要内容
临床试验/NCT00795808
NCT00795808已完成4 期

Multi-Centre Randomised Controlled Trial of the Effectiveness of Metformin and Clomiphene Citrate for Treating Anovulatory Infertility in Women With Polycystic Ovary Syndrome

University of Auckland, New Zealand1 个研究点 分布在 1 个国家目标入组 171 人开始时间: 2003年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
171
试验地点
1
主要终点
Clinical pregnancy

研究概览

简要总结

  1. Metformin increases the pregnancy rate when added to the standard treatment of anovulatory polycystic ovary syndrome (PCOS).
  2. Metformin in combination with clomiphene, is more effective than clomiphene alone or metformin alone improves fertility outcomes in women with PCOS of reasonably healthy body weight (BMI </= 32).
  3. Metformin improves fertility outcomes in women with BMI > 32 with PCOS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 39 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women between the age of 18 and 39 years inclusive.
  • Anovulatory infertility of duration at least 12 months.
  • Polycystic ovary syndrome, based on Rotterdam consensus criteria.
  • Normal serum prolactin, thyroid function and 17-hydroxyprogesterone.
  • Normal serum prolactin, thyroid function and 17-hydroxyprogesterone;

排除标准

  • Presence of any other significant infertility factor including male factor, known tubal disease or history of an ectopic pregnancy, known endometriosis affecting the fallopian tubes or ovaries.
  • Already taking oral hypoglycaemics.
  • Diabetics receiving treatment.
  • Renal impairment
  • Chronic hepatic disease
  • Cardiac Disease
  • Alcohol dependency
  • Pre-disposition to lactic acidosis
  • Previous ovarian drilling procedure, gonadotrophin injection therapy, IUI (intrauterine insemination) or IVF ( in vitro fertilisation).
  • For those women who have had previous fertility treatment, the following would be excluded:
  • Women who have had > 5 cycles of clomiphene citrate
  • Women who have had > 5 months metformin treatment previously
  • Women who have proven to be resistant to 100mg or more of clomiphene citrate.

研究组 & 干预措施

BMI > 32

Experimental

Women with BMI > 32

干预措施: Metformin (Drug)

BMI > 32

Experimental

Women with BMI > 32

干预措施: Placebo (Drug)

BMI </= 32

Experimental

Women with BMI </= 32

干预措施: Metformin + Clomiphene (Drug)

BMI </= 32

Experimental

Women with BMI </= 32

干预措施: Metformin (Drug)

BMI </= 32

Experimental

Women with BMI </= 32

干预措施: Clomiphene (Drug)

结局指标

主要结局

Clinical pregnancy

时间窗: within 6 calendar months of randomisation

次要结局

  • Live birth
  • Adverse events

研究者

发起方
University of Auckland, New Zealand
申办方类型
Other

研究点 (1)

Loading locations...

相似试验